Cristin-resultat-ID: 1962352
Sist endret: 27. januar 2022, 15:27
NVI-rapporteringsår: 2021
Resultat
Vitenskapelig artikkel
2021

Cost-effectiveness analysis of acupuncture compared with usual care for acute non-specific low back pain: secondary analysis of a randomised controlled trial

Bidragsytere:
  • Trygve Skonnord
  • Arne Fetveit
  • Holgeir Skjeie
  • Mette Brekke
  • Margreth Grotle
  • Atle Klovning
  • mfl.

Tidsskrift

Acupuncture in Medicine
ISSN 0964-5284
e-ISSN 1759-9873
NVI-nivå 1

Om resultatet

Vitenskapelig artikkel
Under utgivelse/in press
Publiseringsår: 2021
Publisert online: 2021

Importkilder

Scopus-ID: 2-s2.0-85120456383

Klassifisering

Vitenskapsdisipliner

Allmennmedisin

Emneord

Randomiserte kontrollerte studier • Akupunktur • Allmennmedisin • Kost-nytte analyse

Beskrivelse Beskrivelse

Tittel

Cost-effectiveness analysis of acupuncture compared with usual care for acute non-specific low back pain: secondary analysis of a randomised controlled trial

Sammendrag

Objective: To assess the cost-effectiveness of a single treatment session of acupuncture, when applied in addition to usual care for acute low back pain (ALBP). Methods: Secondary analysis of a multicentre randomised controlled trial in Norwegian general practice. In total, 171 participants with ALBP ⩽14 days were randomised to a control group (CG) receiving usual care or to an acupuncture group (AG) receiving one additional session of Western medical acupuncture alongside usual care. Primary outcome measures for this cost-effectiveness analysis were quality-adjusted life years (QALYs), health care costs and societal costs at days 28 and 365, the incremental cost-effectiveness ratio (ICER) and net monetary benefit (NMB). The NMB was calculated on the basis of the Norwegian cost-effectiveness threshold of NOK 275,000 (USD 35,628) per QALY gained. Missing data were replaced by multiple chained imputation. Results: Eighty-six participants in the CG and 81 in the AG were included in the analysis. We found no QALY gain at day 28. At day 365, the incremental QALY of 0.035 was statistically significant. The differences in health care costs and societal costs were not statistically significant. Three out of four calculations led to negative ICERs (cost saving) and positive NMBs. For the health care perspective at day 365, the ICER was USD –568 per QALY and the NMB was USD 1265, with 95.9% probability of acupuncture being cost-effective. Conclusion: To our knowledge, this is the first cost-effectiveness analysis of acupuncture for ALBP. The findings indicate that acupuncture may be cost-effective from a 1-year perspective, but more studies are needed. Trial registration number: NCT01439412 (ClinicalTrials.gov).

Bidragsytere

Inaktiv cristin-person

Trygve Skonnord

  • Tilknyttet:
    Forfatter
    ved Avdeling for allmennmedisin ved Universitetet i Oslo
Aktiv cristin-person

Arne Fetveit

  • Tilknyttet:
    Forfatter
    ved Avdeling for allmennmedisin ved Universitetet i Oslo

Holgeir Skjeie

  • Tilknyttet:
    Forfatter
    ved Avdeling for allmennmedisin ved Universitetet i Oslo
Aktiv cristin-person

Mette Brekke

  • Tilknyttet:
    Forfatter
    ved Avdeling for allmennmedisin ved Universitetet i Oslo

Margreth Grotle

  • Tilknyttet:
    Forfatter
    ved Institutt for fysioterapi ved OsloMet - storbyuniversitetet
1 - 5 av 7 | Neste | Siste »